Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Skin reactions from cancer treatments might predict how well the treatments work.

Metformin reduces insulin resistance in PCOS, but combining it with finasteride offers extra benefits.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Certain proteins might predict surgical success in trigeminal neuralgia treatment.

Spermidine may improve skin health and hair growth by enhancing cell function.

Extracellular vesicles could help tailor drug treatments, but more research is needed.

CEC levels may be a useful marker for predicting prostate cancer progression.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

Weight loss improves PCOS symptoms and overall health.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.